Morfina Isab Laboratórios Basi – Indústria Farmacêutica (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Morfina Isab, is an opioid analgesic presented as a sterile injectable for epidural, intramuscular, and intrathecal use. It is employed to manage severe acute pain, chronic cancer pain, and postoperative pain in adult patients. GNH USA supplies Morfina Isab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morfina Isab, an opioid analgesic, is indicated for conditions requiring potent pain control. - Severe acute pain: provides rapid, strong analgesia for trauma or injury. - Chronic cancer pain: offers sustained relief for malignant disease‑related discomfort. - Postoperative pain: reduces pain intensity after surgical procedures, facilitating recovery.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset often occurring shortly after dosing. - Constipation: reduced gastrointestinal motility leading to hard stools. - Drowsiness or sedation: increased sleepiness or reduced alertness. - Pruritus: itching, especially after epidural administration. - Dry mouth: decreased salivation. - Urinary retention: difficulty initiating urination.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, potentially fatal. - Hypotension: significant drop in blood pressure. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Dependence or addiction: risk of misuse with prolonged exposure. - Neurotoxicity (intrathecal): rare spinal cord irritation. - Myoclonus: involuntary muscle jerks.

Morphine requires careful monitoring due to its potency and risk profile. - Assess pain level: evaluate severity before initiating therapy. - Monitor respiratory function: watch for signs of depression, especially after dose changes. - Adjust for renal/hepatic impairment: consider dose reduction in organ dysfunction. - Avoid concurrent CNS depressants: limit use with benzodiazepines or alcohol. - Educate patients on constipation management: advise diet, fluids, and laxatives. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Morphine can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - CNS depressants (e.g., benzodiazepines, barbiturates): heightened risk of profound sedation. - MAO inhibitors: risk of severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may increase morphine levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Anticholinergics: may exacerbate constipation. - Diuretics: potential for orthostatic hypotension.